FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

35363311000001106: Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-May 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
106961901000001113 Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106962001000001117 Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) Is a Midostaurin 25mg capsules true Inferred relationship Existential restriction modifier
Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient Midostaurin false Inferred relationship Existential restriction modifier
Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) Is a Rydapt true Inferred relationship Existential restriction modifier
Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) Has active ingredient Substance with protein kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) Has specific active ingredient Midostaurin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) 56 capsule 2 x 28 capsules Has AMP True Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start